Airtec SF 500 Instacap

Description

Airtec SF 500 Instacap is a combination inhalation medicine designed for the long-term management of severe asthma and chronic obstructive pulmonary disease (COPD). It combines Salmeterol, a long-acting bronchodilator that relaxes airway muscles and provides prolonged relief from breathing difficulty, with Fluticasone Propionate, a corticosteroid that reduces lung inflammation and prevents asthma triggers. This higher-strength formulation is especially suitable for patients whose symptoms are not adequately controlled with lower doses.

Uses

• Control and prevention of severe persistent asthma

• Management of advanced COPD, including chronic bronchitis and emphysema

• Reduces risk of asthma flare-ups and hospital admissions

• Improves lung function and quality of life in patients with severe respiratory problems

Dosage

• Typically prescribed as 1 inhalation twice daily, or as directed by the physician.

• Should be taken regularly at the same time every day for consistent control.

• Not meant for acute asthma attacks (a rescue inhaler is required in emergencies).

Possible Side Effects

• Throat irritation, cough, or hoarseness

• Oral fungal infection (thrush) – preventable by rinsing mouth after use

• Headache or dizziness

• Rare: palpitations, tremors, or muscle cramps

• Long-term high-dose use may increase the risk of systemic steroid side effects (should be monitored by the doctor)

About the Company

Glenmark Pharmaceuticals Ltd is a globally recognized pharmaceutical company with strong expertise in respiratory care. It is known for manufacturing reliable, affordable, and patient-friendly inhalation therapies widely prescribed for asthma and COPD across India and abroad.

Good Things About Airtec SF 500

• High-strength formula suitable for patients with severe asthma/COPD

• Provides dual action: long-lasting bronchodilation + anti-inflammatory effect

• Reduces the frequency and severity of breathing difficulties

• Improves patient adherence with easy-to-use instacap technology

• Backed by Glenmark’s reputation in respiratory medicine innovation